世界の子宮筋腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Uterine Fibroid Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5844
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、子宮筋腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（子宮内膜アブレーション、MRIガイド下手術、子宮摘出術、筋腫核出術、子宮動脈塞栓術、高周波アブレーション、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・子宮筋腫治療の市場動向
・企業の競争状況、市場シェア
・子宮筋腫治療の種類別市場規模（子宮内膜アブレーション、MRIガイド下手術、子宮摘出術、筋腫核出術、子宮動脈塞栓術、高周波アブレーション、その他）
・子宮筋腫治療の用途別市場規模（病院、診療所、その他）
・子宮筋腫治療の北米市場規模2016-2027（アメリカ、カナダ）
・子宮筋腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・子宮筋腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・子宮筋腫治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・子宮筋腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Blue Endo、Boston Scientific Corporation、CooperSurgical, Inc.、KARL STORZ SE & Co. KG、Myovant Sciences (Sumitovant Biopharma Ltd.)、Halt Medical, Inc.、LiNA Medical USA、Merit Medical Systems、Olympus Corporation、Richard Wolf GmbH）
・結論

Market Analysis and Insights: Global Uterine Fibroid Treatment Market
The global Uterine Fibroid Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Uterine Fibroid Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Uterine Fibroid Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Uterine Fibroid Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Uterine Fibroid Treatment market.

Global Uterine Fibroid Treatment Scope and Market Size
Uterine Fibroid Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Uterine Fibroid Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Endometrial Ablation
MRI Guided Procedures
Hysterectomy
Myomectomy
Uterine Artery Embolization
Radiofrequency Ablation
Others

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Blue Endo
Boston Scientific Corporation
CooperSurgical, Inc.
KARL STORZ SE & Co. KG
Myovant Sciences (Sumitovant Biopharma Ltd.)
Halt Medical, Inc.
LiNA Medical USA
Merit Medical Systems

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Uterine Fibroid Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Endometrial Ablation
1.2.3 MRI Guided Procedures
1.2.4 Hysterectomy
1.2.5 Myomectomy
1.2.6 Uterine Artery Embolization
1.2.7 Radiofrequency Ablation
1.2.8 Others
1.3 Market by Application
1.3.1 Global Uterine Fibroid Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Uterine Fibroid Treatment Market Perspective (2016-2027)
2.2 Uterine Fibroid Treatment Growth Trends by Regions
2.2.1 Uterine Fibroid Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Uterine Fibroid Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Uterine Fibroid Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Uterine Fibroid Treatment Industry Dynamic
2.3.1 Uterine Fibroid Treatment Market Trends
2.3.2 Uterine Fibroid Treatment Market Drivers
2.3.3 Uterine Fibroid Treatment Market Challenges
2.3.4 Uterine Fibroid Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Uterine Fibroid Treatment Players by Revenue
3.1.1 Global Top Uterine Fibroid Treatment Players by Revenue (2016-2021)
3.1.2 Global Uterine Fibroid Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Uterine Fibroid Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Uterine Fibroid Treatment Revenue
3.4 Global Uterine Fibroid Treatment Market Concentration Ratio
3.4.1 Global Uterine Fibroid Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Uterine Fibroid Treatment Revenue in 2020
3.5 Uterine Fibroid Treatment Key Players Head office and Area Served
3.6 Key Players Uterine Fibroid Treatment Product Solution and Service
3.7 Date of Enter into Uterine Fibroid Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Uterine Fibroid Treatment Breakdown Data by Type
4.1 Global Uterine Fibroid Treatment Historic Market Size by Type (2016-2021)
4.2 Global Uterine Fibroid Treatment Forecasted Market Size by Type (2022-2027)

5 Uterine Fibroid Treatment Breakdown Data by Application
5.1 Global Uterine Fibroid Treatment Historic Market Size by Application (2016-2021)
5.2 Global Uterine Fibroid Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Uterine Fibroid Treatment Market Size (2016-2027)
6.2 North America Uterine Fibroid Treatment Market Size by Type
6.2.1 North America Uterine Fibroid Treatment Market Size by Type (2016-2021)
6.2.2 North America Uterine Fibroid Treatment Market Size by Type (2022-2027)
6.2.3 North America Uterine Fibroid Treatment Market Size by Type (2016-2027)
6.3 North America Uterine Fibroid Treatment Market Size by Application
6.3.1 North America Uterine Fibroid Treatment Market Size by Application (2016-2021)
6.3.2 North America Uterine Fibroid Treatment Market Size by Application (2022-2027)
6.3.3 North America Uterine Fibroid Treatment Market Size by Application (2016-2027)
6.4 North America Uterine Fibroid Treatment Market Size by Country
6.4.1 North America Uterine Fibroid Treatment Market Size by Country (2016-2021)
6.4.2 North America Uterine Fibroid Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Uterine Fibroid Treatment Market Size (2016-2027)
7.2 Europe Uterine Fibroid Treatment Market Size by Type
7.2.1 Europe Uterine Fibroid Treatment Market Size by Type (2016-2021)
7.2.2 Europe Uterine Fibroid Treatment Market Size by Type (2022-2027)
7.2.3 Europe Uterine Fibroid Treatment Market Size by Type (2016-2027)
7.3 Europe Uterine Fibroid Treatment Market Size by Application
7.3.1 Europe Uterine Fibroid Treatment Market Size by Application (2016-2021)
7.3.2 Europe Uterine Fibroid Treatment Market Size by Application (2022-2027)
7.3.3 Europe Uterine Fibroid Treatment Market Size by Application (2016-2027)
7.4 Europe Uterine Fibroid Treatment Market Size by Country
7.4.1 Europe Uterine Fibroid Treatment Market Size by Country (2016-2021)
7.4.2 Europe Uterine Fibroid Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Uterine Fibroid Treatment Market Size (2016-2027)
8.2 Asia-Pacific Uterine Fibroid Treatment Market Size by Type
8.2.1 Asia-Pacific Uterine Fibroid Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Uterine Fibroid Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Uterine Fibroid Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Uterine Fibroid Treatment Market Size by Application
8.3.1 Asia-Pacific Uterine Fibroid Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Uterine Fibroid Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Uterine Fibroid Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Uterine Fibroid Treatment Market Size by Region
8.4.1 Asia-Pacific Uterine Fibroid Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Uterine Fibroid Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Uterine Fibroid Treatment Market Size (2016-2027)
9.2 Latin America Uterine Fibroid Treatment Market Size by Type
9.2.1 Latin America Uterine Fibroid Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Uterine Fibroid Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Uterine Fibroid Treatment Market Size by Type (2016-2027)
9.3 Latin America Uterine Fibroid Treatment Market Size by Application
9.3.1 Latin America Uterine Fibroid Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Uterine Fibroid Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Uterine Fibroid Treatment Market Size by Application (2016-2027)
9.4 Latin America Uterine Fibroid Treatment Market Size by Country
9.4.1 Latin America Uterine Fibroid Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Uterine Fibroid Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Uterine Fibroid Treatment Market Size (2016-2027)
10.2 Middle East & Africa Uterine Fibroid Treatment Market Size by Type
10.2.1 Middle East & Africa Uterine Fibroid Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Uterine Fibroid Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Uterine Fibroid Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Uterine Fibroid Treatment Market Size by Application
10.3.1 Middle East & Africa Uterine Fibroid Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Uterine Fibroid Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Uterine Fibroid Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Uterine Fibroid Treatment Market Size by Country
10.4.1 Middle East & Africa Uterine Fibroid Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Uterine Fibroid Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Blue Endo
11.1.1 Blue Endo Company Details
11.1.2 Blue Endo Business Overview
11.1.3 Blue Endo Uterine Fibroid Treatment Introduction
11.1.4 Blue Endo Revenue in Uterine Fibroid Treatment Business (2016-2021)
11.1.5 Blue Endo Recent Development
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Details
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Uterine Fibroid Treatment Introduction
11.2.4 Boston Scientific Corporation Revenue in Uterine Fibroid Treatment Business (2016-2021)
11.2.5 Boston Scientific Corporation Recent Development
11.3 CooperSurgical, Inc.
11.3.1 CooperSurgical, Inc. Company Details
11.3.2 CooperSurgical, Inc. Business Overview
11.3.3 CooperSurgical, Inc. Uterine Fibroid Treatment Introduction
11.3.4 CooperSurgical, Inc. Revenue in Uterine Fibroid Treatment Business (2016-2021)
11.3.5 CooperSurgical, Inc. Recent Development
11.4 KARL STORZ SE & Co. KG
11.4.1 KARL STORZ SE & Co. KG Company Details
11.4.2 KARL STORZ SE & Co. KG Business Overview
11.4.3 KARL STORZ SE & Co. KG Uterine Fibroid Treatment Introduction
11.4.4 KARL STORZ SE & Co. KG Revenue in Uterine Fibroid Treatment Business (2016-2021)
11.4.5 KARL STORZ SE & Co. KG Recent Development
11.5 Myovant Sciences (Sumitovant Biopharma Ltd.)
11.5.1 Myovant Sciences (Sumitovant Biopharma Ltd.) Company Details
11.5.2 Myovant Sciences (Sumitovant Biopharma Ltd.) Business Overview
11.5.3 Myovant Sciences (Sumitovant Biopharma Ltd.) Uterine Fibroid Treatment Introduction
11.5.4 Myovant Sciences (Sumitovant Biopharma Ltd.) Revenue in Uterine Fibroid Treatment Business (2016-2021)
11.5.5 Myovant Sciences (Sumitovant Biopharma Ltd.) Recent Development
11.6 Halt Medical, Inc.
11.6.1 Halt Medical, Inc. Company Details
11.6.2 Halt Medical, Inc. Business Overview
11.6.3 Halt Medical, Inc. Uterine Fibroid Treatment Introduction
11.6.4 Halt Medical, Inc. Revenue in Uterine Fibroid Treatment Business (2016-2021)
11.6.5 Halt Medical, Inc. Recent Development
11.7 LiNA Medical USA
11.7.1 LiNA Medical USA Company Details
11.7.2 LiNA Medical USA Business Overview
11.7.3 LiNA Medical USA Uterine Fibroid Treatment Introduction
11.7.4 LiNA Medical USA Revenue in Uterine Fibroid Treatment Business (2016-2021)
11.7.5 LiNA Medical USA Recent Development
11.8 Merit Medical Systems
11.8.1 Merit Medical Systems Company Details
11.8.2 Merit Medical Systems Business Overview
11.8.3 Merit Medical Systems Uterine Fibroid Treatment Introduction
11.8.4 Merit Medical Systems Revenue in Uterine Fibroid Treatment Business (2016-2021)
11.8.5 Merit Medical Systems Recent Development
11.9 Olympus Corporation
11.9.1 Olympus Corporation Company Details
11.9.2 Olympus Corporation Business Overview
11.9.3 Olympus Corporation Uterine Fibroid Treatment Introduction
11.9.4 Olympus Corporation Revenue in Uterine Fibroid Treatment Business (2016-2021)
11.9.5 Olympus Corporation Recent Development
11.10 Richard Wolf GmbH
11.10.1 Richard Wolf GmbH Company Details
11.10.2 Richard Wolf GmbH Business Overview
11.10.3 Richard Wolf GmbH Uterine Fibroid Treatment Introduction
11.10.4 Richard Wolf GmbH Revenue in Uterine Fibroid Treatment Business (2016-2021)
11.10.5 Richard Wolf GmbH Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Uterine Fibroid Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Endometrial Ablation
Table 3. Key Players of MRI Guided Procedures
Table 4. Key Players of Hysterectomy
Table 5. Key Players of Myomectomy
Table 6. Key Players of Uterine Artery Embolization
Table 7. Key Players of Radiofrequency Ablation
Table 8. Key Players of Others
Table 9. Global Uterine Fibroid Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Uterine Fibroid Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Uterine Fibroid Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Uterine Fibroid Treatment Market Share by Regions (2016-2021)
Table 13. Global Uterine Fibroid Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Uterine Fibroid Treatment Market Share by Regions (2022-2027)
Table 15. Uterine Fibroid Treatment Market Trends
Table 16. Uterine Fibroid Treatment Market Drivers
Table 17. Uterine Fibroid Treatment Market Challenges
Table 18. Uterine Fibroid Treatment Market Restraints
Table 19. Global Uterine Fibroid Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Uterine Fibroid Treatment Market Share by Players (2016-2021)
Table 21. Global Top Uterine Fibroid Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Fibroid Treatment as of 2020)
Table 22. Ranking of Global Top Uterine Fibroid Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Uterine Fibroid Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Uterine Fibroid Treatment Product Solution and Service
Table 26. Date of Enter into Uterine Fibroid Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Uterine Fibroid Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Uterine Fibroid Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Uterine Fibroid Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Uterine Fibroid Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Uterine Fibroid Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Uterine Fibroid Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Uterine Fibroid Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Uterine Fibroid Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Uterine Fibroid Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Uterine Fibroid Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Uterine Fibroid Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Uterine Fibroid Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Uterine Fibroid Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Uterine Fibroid Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Uterine Fibroid Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Uterine Fibroid Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Uterine Fibroid Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Uterine Fibroid Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Uterine Fibroid Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Uterine Fibroid Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Uterine Fibroid Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Uterine Fibroid Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Uterine Fibroid Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Uterine Fibroid Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Uterine Fibroid Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Uterine Fibroid Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Uterine Fibroid Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Uterine Fibroid Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Uterine Fibroid Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Uterine Fibroid Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Uterine Fibroid Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Uterine Fibroid Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Uterine Fibroid Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Uterine Fibroid Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Uterine Fibroid Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Uterine Fibroid Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Uterine Fibroid Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Uterine Fibroid Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. Blue Endo Company Details
Table 67. Blue Endo Business Overview
Table 68. Blue Endo Uterine Fibroid Treatment Product
Table 69. Blue Endo Revenue in Uterine Fibroid Treatment Business (2016-2021) & (US$ Million)
Table 70. Blue Endo Recent Development
Table 71. Boston Scientific Corporation Company Details
Table 72. Boston Scientific Corporation Business Overview
Table 73. Boston Scientific Corporation Uterine Fibroid Treatment Product
Table 74. Boston Scientific Corporation Revenue in Uterine Fibroid Treatment Business (2016-2021) & (US$ Million)
Table 75. Boston Scientific Corporation Recent Development
Table 76. CooperSurgical, Inc. Company Details
Table 77. CooperSurgical, Inc. Business Overview
Table 78. CooperSurgical, Inc. Uterine Fibroid Treatment Product
Table 79. CooperSurgical, Inc. Revenue in Uterine Fibroid Treatment Business (2016-2021) & (US$ Million)
Table 80. CooperSurgical, Inc. Recent Development
Table 81. KARL STORZ SE & Co. KG Company Details
Table 82. KARL STORZ SE & Co. KG Business Overview
Table 83. KARL STORZ SE & Co. KG Uterine Fibroid Treatment Product
Table 84. KARL STORZ SE & Co. KG Revenue in Uterine Fibroid Treatment Business (2016-2021) & (US$ Million)
Table 85. KARL STORZ SE & Co. KG Recent Development
Table 86. Myovant Sciences (Sumitovant Biopharma Ltd.) Company Details
Table 87. Myovant Sciences (Sumitovant Biopharma Ltd.) Business Overview
Table 88. Myovant Sciences (Sumitovant Biopharma Ltd.) Uterine Fibroid Treatment Product
Table 89. Myovant Sciences (Sumitovant Biopharma Ltd.) Revenue in Uterine Fibroid Treatment Business (2016-2021) & (US$ Million)
Table 90. Myovant Sciences (Sumitovant Biopharma Ltd.) Recent Development
Table 91. Halt Medical, Inc. Company Details
Table 92. Halt Medical, Inc. Business Overview
Table 93. Halt Medical, Inc. Uterine Fibroid Treatment Product
Table 94. Halt Medical, Inc. Revenue in Uterine Fibroid Treatment Business (2016-2021) & (US$ Million)
Table 95. Halt Medical, Inc. Recent Development
Table 96. LiNA Medical USA Company Details
Table 97. LiNA Medical USA Business Overview
Table 98. LiNA Medical USA Uterine Fibroid Treatment Product
Table 99. LiNA Medical USA Revenue in Uterine Fibroid Treatment Business (2016-2021) & (US$ Million)
Table 100. LiNA Medical USA Recent Development
Table 101. Merit Medical Systems Company Details
Table 102. Merit Medical Systems Business Overview
Table 103. Merit Medical Systems Revenue in Uterine Fibroid Treatment Business (2016-2021) & (US$ Million)
Table 104. Merit Medical Systems Recent Development
Table 105. Olympus Corporation Company Details
Table 106. Olympus Corporation Business Overview
Table 107. Olympus Corporation Uterine Fibroid Treatment Product
Table 108. Olympus Corporation Revenue in Uterine Fibroid Treatment Business (2016-2021) & (US$ Million)
Table 109. Olympus Corporation Recent Development
Table 110. Richard Wolf GmbH Company Details
Table 111. Richard Wolf GmbH Business Overview
Table 112. Richard Wolf GmbH Uterine Fibroid Treatment Product
Table 113. Richard Wolf GmbH Revenue in Uterine Fibroid Treatment Business (2016-2021) & (US$ Million)
Table 114. Richard Wolf GmbH Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Uterine Fibroid Treatment Market Share by Type: 2020 VS 2027
Figure 2. Endometrial Ablation Features
Figure 3. MRI Guided Procedures Features
Figure 4. Hysterectomy Features
Figure 5. Myomectomy Features
Figure 6. Uterine Artery Embolization Features
Figure 7. Radiofrequency Ablation Features
Figure 8. Others Features
Figure 9. Global Uterine Fibroid Treatment Market Share by Application: 2020 VS 2027
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. Uterine Fibroid Treatment Report Years Considered
Figure 14. Global Uterine Fibroid Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Uterine Fibroid Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Uterine Fibroid Treatment Market Share by Regions: 2020 VS 2027
Figure 17. Global Uterine Fibroid Treatment Market Share by Regions (2022-2027)
Figure 18. Global Uterine Fibroid Treatment Market Share by Players in 2020
Figure 19. Global Top Uterine Fibroid Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Fibroid Treatment as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Uterine Fibroid Treatment Revenue in 2020
Figure 21. Global Uterine Fibroid Treatment Revenue Market Share by Type (2016-2021)
Figure 22. Global Uterine Fibroid Treatment Revenue Market Share by Type (2022-2027)
Figure 23. North America Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Uterine Fibroid Treatment Market Share by Type (2016-2027)
Figure 25. North America Uterine Fibroid Treatment Market Share by Application (2016-2027)
Figure 26. North America Uterine Fibroid Treatment Market Share by Country (2016-2027)
Figure 27. United States Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Uterine Fibroid Treatment Market Share by Type (2016-2027)
Figure 31. Europe Uterine Fibroid Treatment Market Share by Application (2016-2027)
Figure 32. Europe Uterine Fibroid Treatment Market Share by Country (2016-2027)
Figure 33. Germany Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Uterine Fibroid Treatment Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Uterine Fibroid Treatment Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Uterine Fibroid Treatment Market Share by Region (2016-2027)
Figure 43. China Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Uterine Fibroid Treatment Market Share by Type (2016-2027)
Figure 51. Latin America Uterine Fibroid Treatment Market Share by Application (2016-2027)
Figure 52. Latin America Uterine Fibroid Treatment Market Share by Country (2016-2027)
Figure 53. Mexico Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Uterine Fibroid Treatment Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Uterine Fibroid Treatment Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Uterine Fibroid Treatment Market Share by Country (2016-2027)
Figure 59. Turkey Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Uterine Fibroid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Blue Endo Revenue Growth Rate in Uterine Fibroid Treatment Business (2016-2021)
Figure 63. Boston Scientific Corporation Revenue Growth Rate in Uterine Fibroid Treatment Business (2016-2021)
Figure 64. CooperSurgical, Inc. Revenue Growth Rate in Uterine Fibroid Treatment Business (2016-2021)
Figure 65. KARL STORZ SE & Co. KG Revenue Growth Rate in Uterine Fibroid Treatment Business (2016-2021)
Figure 66. Myovant Sciences (Sumitovant Biopharma Ltd.) Revenue Growth Rate in Uterine Fibroid Treatment Business (2016-2021)
Figure 67. Halt Medical, Inc. Revenue Growth Rate in Uterine Fibroid Treatment Business (2016-2021)
Figure 68. LiNA Medical USA Revenue Growth Rate in Uterine Fibroid Treatment Business (2016-2021)
Figure 69. Merit Medical Systems Revenue Growth Rate in Uterine Fibroid Treatment Business (2016-2021)
Figure 70. Olympus Corporation Revenue Growth Rate in Uterine Fibroid Treatment Business (2016-2021)
Figure 71. Richard Wolf GmbH Revenue Growth Rate in Uterine Fibroid Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Global Acute and Chronic Abnormal Uterine Bleeding Market Size, Status and Forecast 2021-2027
QYR2104Z0051 2021年4月 93Pages
QYResearch社発行の本調査資料では、急性・慢性異常子宮出血（AUB）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン療法、非ホルモン療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の子宮筋腫市場規模・現状・予測（2021年-2027年）

Global Uterine Fibroids Market Size, Status and Forecast 2021-2027
QYR2104Z5845 2021年4月 133Pages
QYResearch社発行の本調査資料では、子宮筋腫のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非ホルモン療法、ホルモン療法）、用途別市場規模（病院、外来手術センター、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界の医療排水処理市場規模・現状・予測（2021年-2027年）

Global Medical Waste Water Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3664 2021年4月 97Pages
QYResearch社発行の本調査資料では、医療排水処理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（感染性排水、有害排水、放射性排水、一般排水）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の医療排水処理市場規模・現状・予測（2021年-2027年）

世界の医療廃棄物処理市場規模・現状・予測（2021年-2027年）

Global Medical Waste Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3663 2021年4月 127Pages
QYResearch社発行の本調査資料では、医療廃棄物処理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（焼却、オートクレーブ、その他）、用途別市場規模（感染性廃棄物、有害廃棄物、放射性廃棄物、一般廃棄物）、主要地域別市場規模（北米、アメリカ、...

世界のエネルギーベース非侵襲的医療エステティック施術システム市場規模・現状・予測（2021年-2027年）

Global Energy-based Non-invasive Medical Aesthetic Treatment System Market Size, Status and Forecast 2021-2027
QYR2104Z2183 2021年4月 93Pages
QYResearch社発行の本調査資料では、エネルギーベース非侵襲的医療エステティック施術システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射剤、エネルギーデバイス、薬用化粧品、美容整形、フェイシャルエステティック、インプラント、美容観...

世界の胸水治療市場規模・現状・予測（2021年-2027年）

Global Pleural Effusions Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4656 2021年4月 99Pages
QYResearch社発行の本調査資料では、胸水治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（胸腔穿刺、胸膜癒着術、胸膜癒着術、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界のディンプルプラスティ治療市場規模・現状・予測（2021年-2027年）

Global Dimpleplasty Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1899 2021年4月 98Pages
QYResearch社発行の本調査資料では、ディンプルプラスティ治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（光線療法、レーザー治療、その他）、用途別市場規模（病院、皮膚科クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の静脈内レーザー治療市場規模・現状・予測（2021年-2027年）

Global Endovenous Laser Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2170 2021年4月 98Pages
QYResearch社発行の本調査資料では、静脈内レーザー治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内レーザーシステム、静脈内レーザーファイバー）、用途別市場規模（病院、外来手術センター、専門クリニック）、主要地域別市場規模（北米...

世界の腹水治療市場規模・現状・予測（2021年-2027年）

Global Ascites Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0472 2021年4月 94Pages
QYResearch社発行の本調査資料では、腹水治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、穿刺、肝移植、その他）、用途別市場規模（外来手術センター、病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の急性・慢性異常子宮出血（AUB）市場規模・現状・予測（2021年-2027年） Abnormal uterine bleeding (AUB) may be acute or chronic and is defined as bleeding from the uterine corpus that is abnormal in regularity, volume, frequency, or duration and occurs in the absence of pregnancy. Market Analysis and Insights: Global Acute and Chronic Abnormal Uterine Bleeding Market Th…
世界の子宮筋腫市場規模・現状・予測（2021年-2027年） Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%–40% in women during their reproductive ages. Occasional…
世界の子宮内膜アブレーション市場規模・現状・予測（2021年-2027年） Endometrial ablation is a non-invasive procedure which results in destruction of or ablation of the outermost lining of uterus called endometrium. The endometrial ablation is essentially used in the treatment of abnormal uterine bleeding. In addition, prolonged abnormal uterine bleeding can result i…
世界のカテーテルアブレーション市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Radiofrequency Ablation Market The global Radiofrequency Ablation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
世界の尿抑制剤市場 2021：企業別、地域別、種類・用途別 The Uterine Depressor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …